SHUKRAPHAR Stock Chart & Stats
₹41.51
--
Market closed
₹41.51
--
Day’s Range― - ―
52-Week Range₹25.21 - ₹65.26
Previous CloseN/A
VolumeN/A
Average Volume (3M)N/A
Market Cap
₹19.44B
Enterprise Value₹15.61K
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)57.1
Beta-0.11
Next Earnings
Nov 09, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.29
Shares Outstanding439,614,440
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
SHUKRAPHAR FAQ
What was Shukra Pharmaceuticals Ltd.’s price range in the past 12 months?
Shukra Pharmaceuticals Ltd. lowest stock price was ₹25.21 and its highest was ₹65.26 in the past 12 months.
What is Shukra Pharmaceuticals Ltd.’s market cap?
Shukra Pharmaceuticals Ltd.’s market cap is ₹19.44B.
When is Shukra Pharmaceuticals Ltd.’s upcoming earnings report date?
Shukra Pharmaceuticals Ltd.’s upcoming earnings report date is Nov 09, 2026 which is in 73 days.
How were Shukra Pharmaceuticals Ltd.’s earnings last quarter?
Shukra Pharmaceuticals Ltd. released its earnings results on Aug 12, 2026. The company reported ₹0.295 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Shukra Pharmaceuticals Ltd. overvalued?
According to Wall Street analysts Shukra Pharmaceuticals Ltd.’s price is currently Overvalued.
Does Shukra Pharmaceuticals Ltd. pay dividends?
Shukra Pharmaceuticals Ltd. does not currently pay dividends.
What is Shukra Pharmaceuticals Ltd.’s EPS estimate?
Shukra Pharmaceuticals Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Shukra Pharmaceuticals Ltd. have?
Shukra Pharmaceuticals Ltd. has 439,614,440 shares outstanding.
What happened to Shukra Pharmaceuticals Ltd.’s price movement after its last earnings report?
Shukra Pharmaceuticals Ltd. reported an EPS of ₹0.295 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 6.871%.
Which hedge fund is a major shareholder of Shukra Pharmaceuticals Ltd.?
Currently, no hedge funds are holding shares in IN:SHUKRAPHAR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology